A detailed history of Bamco Inc transactions in Dexcom Inc stock. As of the latest transaction made, Bamco Inc holds 564,854 shares of DXCM stock, worth $42.5 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
564,854
Previous 966,472 41.56%
Holding current value
$42.5 Million
Previous $110 Million 65.45%
% of portfolio
0.1%
Previous 0.32%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $25.7 Million - $46.6 Million
-401,618 Reduced 41.56%
564,854 $37.9 Million
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $166,678 - $212,219
-1,511 Reduced 0.16%
966,472 $110 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $3.4 Million - $4.16 Million
-29,725 Reduced 2.98%
967,983 $134 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $24.3 Million - $39.9 Million
-321,358 Reduced 24.36%
997,708 $124 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $9.29 Million - $14.9 Million
-107,924 Reduced 7.56%
1,319,066 $123 Million
Q2 2023

Aug 14, 2023

SELL
$112.47 - $130.98 $1.14 Million - $1.33 Million
-10,150 Reduced 0.71%
1,426,990 $183 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $8.48 Million - $10 Million
81,553 Added 6.02%
1,437,140 $167 Million
Q4 2022

Feb 14, 2023

SELL
$84.98 - $122.67 $9.79 Million - $14.1 Million
-115,159 Reduced 7.83%
1,355,587 $154 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $51,307 - $63,288
672 Added 0.05%
1,470,746 $118 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $74.8 Million - $146 Million
1,100,105 Added 297.35%
1,470,074 $110 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $1.03 Million - $1.42 Million
-10,919 Reduced 2.87%
369,969 $189 Million
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $2.38 Million - $2.99 Million
-18,358 Reduced 4.6%
380,888 $205 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $322,264 - $432,403
3,020 Added 0.76%
399,246 $218 Million
Q2 2021

Aug 13, 2021

SELL
$80.99 - $107.93 $1.56 Million - $2.08 Million
-19,311 Reduced 4.65%
396,226 $169 Million
Q1 2021

May 19, 2021

SELL
$84.79 - $104.74 $84,111 - $103,902
-992 Reduced 0.24%
415,537 $149 Million
Q4 2020

Feb 12, 2021

SELL
$78.0 - $104.5 $5,226 - $7,001
-67 Reduced 0.02%
416,529 $154 Million
Q3 2020

Nov 13, 2020

SELL
$95.51 - $112.95 $5.26 Million - $6.22 Million
-55,080 Reduced 11.68%
416,596 $172 Million
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $1.77 Million - $2.97 Million
-28,168 Reduced 5.64%
471,676 $191 Million
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $408,126 - $645,880
-8,540 Reduced 1.68%
499,844 $135 Million
Q4 2019

Feb 18, 2020

BUY
$36.62 - $57.29 $17,248 - $26,983
471 Added 0.09%
508,384 $111 Million
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $272,479 - $335,902
7,669 Added 1.53%
507,913 $75.8 Million
Q2 2019

Aug 15, 2019

BUY
$27.84 - $38.92 $2.4 Million - $3.36 Million
86,347 Added 20.86%
500,244 $75 Million
Q1 2019

May 15, 2019

BUY
$28.07 - $38.18 $3.14 Million - $4.27 Million
111,916 Added 37.06%
413,897 $49.3 Million
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $8,636 - $11,958
320 Added 0.11%
301,981 $36.2 Million
Q3 2018

Nov 14, 2018

BUY
$23.35 - $36.72 $15,434 - $24,271
661 Added 0.22%
301,661 $43.2 Million
Q3 2017

Nov 15, 2017

BUY
$11.36 - $18.98 $3.42 Million - $5.71 Million
301,000
301,000 $14.7 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.